Key Points
- Director Donald Morel, Jr. bought 25,000 shares at an average €13.07 each, spending €326,750. The purchase increased his direct stake by 66.8% to 62,424 shares.
- Stevanato reported quarterly EPS of €0.16, missing analysts’ €0.17 consensus; revenue was €326.06 million.
- Analysts’ consensus rating is Moderate Buy, with two Strong Buy, two Buy, and five Hold ratings; Citigroup and UBS recently reduced their price targets.
Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) Director Donald Morel, Jr. acquired 25,000 shares of the firm's stock in a transaction on Friday, November 6th. The shares were bought at an average cost of €13.07 per share, for a total transaction of €326,750.00. Following the completion of the acquisition, the director directly owned 62,424 shares of the company's stock, valued at approximately €815,881.68. This represents a 66.80% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Stevanato Group Trading Down 0.7%
STVN stock opened at €13.44 on Wednesday. Stevanato Group S.p.A. has a 1-year low of €12.05 and a 1-year high of €25.45. The firm has a market cap of $4.07 billion, a P/E ratio of 23.16, a P/E/G ratio of 1.42 and a beta of 0.80. The business's 50 day moving average is €19.49 and its 200-day moving average is €17.95. The company has a current ratio of 1.73, a quick ratio of 1.19 and a debt-to-equity ratio of 0.22.
Stevanato Group (NYSE:STVN - Get Free Report) last issued its earnings results on Tuesday, November 3rd. The company reported €0.16 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of €0.17 by (€0.01). The company had revenue of €326.06 million during the quarter. Stevanato Group had a return on equity of 10.51% and a net margin of 11.24%. Equities analysts anticipate that Stevanato Group S.p.A. will post 0.67 earnings per share for the current fiscal year.
Institutional Trading of Stevanato Group
Several hedge funds have recently modified their holdings of STVN. Ieq Capital LLC bought a new stake in Stevanato Group during the 3rd quarter worth approximately $292,000. Montanaro Asset Management Ltd increased its holdings in Stevanato Group by 42.4% during the 3rd quarter. Montanaro Asset Management Ltd now owns 200,000 shares of the company's stock valued at $4,196,000 after purchasing an additional 59,541 shares in the last quarter. Russell Investments Group Ltd. increased its holdings in Stevanato Group by 2.4% during the 3rd quarter. Russell Investments Group Ltd. now owns 274,637 shares of the company's stock valued at $5,762,000 after purchasing an additional 6,542 shares in the last quarter. Riverbridge Partners LLC raised its position in Stevanato Group by 4.2% in the 3rd quarter. Riverbridge Partners LLC now owns 625,914 shares of the company's stock valued at $13,132,000 after purchasing an additional 25,400 shares during the last quarter. Finally, State of Wyoming bought a new position in Stevanato Group in the 3rd quarter valued at $75,000.
Wall Street Analyst Weigh In
Several research analysts have issued reports on STVN shares. Deutsche Bank Aktiengesellschaft started coverage on Stevanato Group in a research note on Wednesday, October 7th. They set a "hold" rating for the company. Citigroup cut their price objective on Stevanato Group from $26.00 to $20.00 and set a "buy" rating for the company in a report on Wednesday, November 4th. Weiss Ratings upgraded shares of Stevanato Group from a "hold (c-)" rating to a "hold (c)" rating in a research note on Thursday, August 27th. William Blair lowered shares of Stevanato Group from an "outperform" rating to a "market perform" rating in a report on Wednesday, November 4th. Finally, UBS Group lowered their target price on shares of Stevanato Group from $23.00 to $16.00 and set a "neutral" rating on the stock in a report on Wednesday, November 4th. Two investment analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and five have given a Hold rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy".
Read Our Latest Stock Analysis on STVN
About Stevanato Group
(
Get Free Report)
Stevanato Group is an Italian provider of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and diagnostic industries. Founded in 1949 by Giovanni Stevanato, the company began as a glassmaking business and has expanded into a global supplier of products and services for the life sciences sector. The company makes primary packaging for injectable medicines, including glass vials, cartridges, syringes and ampoules. Its offerings also include ready-to-use containers, as well as services such as product development, analytical testing and packaging support.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
